The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study to investigate the deepness of response (DpR) of FOLFOXIRI plus cetuximab (Erbitux) versus FOLFOXIRI plus bevacizumab as the first-line therapy in metastatic colorectal cancer (mCRC) patients with RAS wild-type tumors: DEEPER.
 
Akihito Tsuji
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda
 
Yu Sunakawa
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Yakult Honsha (Inst)
 
Wataru Ichikawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Nippon Kayaku; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono; Ono Pharmaceutical; Zeria Pharmaceutical
Research Funding - Eisai; Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Yutaro Kubota
No Relationships to Disclose
 
Mitsugu Kochi
No Relationships to Disclose
 
Takashi Sekikawa
No Relationships to Disclose
 
Tamotsu Sagawa
No Relationships to Disclose
 
Masahito Kotaka
Honoraria - Chugai Pharma; Merck Serono; Takeda; Yakult Honsha
 
Masato Nakamura
No Relationships to Disclose
 
Ken Shimada
No Relationships to Disclose
 
Toshiki Masuishi
Honoraria - Chugai Pharma; Merck Serono; Takeda; Yakult Honsha
 
Hironaga Satake
No Relationships to Disclose
 
Taichi Yabuno
No Relationships to Disclose
 
Taichi Yoshida
No Relationships to Disclose
 
Masahiro Goto
No Relationships to Disclose
 
Hirofumi Ota
No Relationships to Disclose
 
Yoshihiro Okita
No Relationships to Disclose
 
Masahiro Takeuchi
Honoraria - Mitsubishi Tanabe Pharma
Consulting or Advisory Role - Abbvie; AstraZeneca Japan; Hisamitsu Pharmaceutical; Kowa; Shionogi; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AnGes
 
Masashi Fujii
Stock and Other Ownership Interests - Otsuka (I)
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization
 
Toshifusa Nakajima
Honoraria - Taiho Pharmaceutical